Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serologic Study of FluvalAB Influenza Vaccine (Trivalent, Seasonal) for 2009-2010 Season
2009-012555-22Phase 4Completed
- Sponsor
- Omninvest
- Start
- Jun 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of FluvalAB in influenza and seasonal influenza (2 arms), sponsored by Omninvest. Primary endpoints: Seroconversion ratio in 18–60 years age group and Seroconversion ratio in over 60 years age group. Started Jun 2009; status: completed.
02
Drugs
FluvalAB
03
Conditions
influenzaseasonal influenza
Beyond the preview
Go deeper on 2009-012555-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012555-22.